Effects of humanized recombinant CD25 monoclonal antibody on activation and proliferation of t lymphocytes / 中国实验血液学杂志
Journal of Experimental Hematology
; (6): 134-137, 2007.
Article
en Zh
| WPRIM
| ID: wpr-230316
Biblioteca responsable:
WPRO
ABSTRACT
The study was purposed to investigate the effects of humanized recombined CD25 monoclonal antibody (rhCD25MAb) on activation and proliferation of T lymphocytes in vitro. Peripheral blood mononuclear cells (PBMNC) were incubated with phytohemagglutinin (PHA). Before or after T cell activation, the cells were cultured with or without rhCD25MAb or cyclosporine A (CsA) in vitro. After 72 hours incubation, the proliferation of lymphocytes was analyzed by MTT assay. The expression of CD3 and CD25 antigens on T lymphocytes were detected by flow cytometry. The levels of sIL-2R in the supernatants were determined with ELISA. The results showed that both rhCD25MAb and CsA could inhibit the proliferation of T lymphocytes significantly in concentration-dependent manner and CsA was more efficient than rhCD25MAb. Both rhCD25MAb and CsA could also decrease the levels of sIL-2R in the supernatant and inhibit the expression of CD25 antigen on T lymphocytes. The level of sIL-2R and the expression of CD25 on T lymphocytes decreases more profoundly in rhCD25MAb group. It is concluded that rhCD25MAb shows strong immunosuppressive activity both before and after T cell activation, suggesting that this agent may be useful in not only prophylaxis but also the treatment of acute graft-versus-host disease.
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Farmacología
/
Proteínas Recombinantes
/
Activación de Linfocitos
/
Linfocitos T
/
Receptores de Interleucina-2
/
Células Cultivadas
/
Ciclosporina
/
Complejo CD3
/
Proliferación Celular
/
Alergia e Inmunología
Límite:
Humans
Idioma:
Zh
Revista:
Journal of Experimental Hematology
Año:
2007
Tipo del documento:
Article